493 related articles for article (PubMed ID: 16319059)
21. A Panel of Recombinant Mucins Carrying a Repertoire of Sialylated O-Glycans Based on Different Core Chains for Studies of Glycan Binding Proteins.
Cherian RM; Jin C; Liu J; Karlsson NG; Holgersson J
Biomolecules; 2015 Aug; 5(3):1810-31. PubMed ID: 26274979
[TBL] [Abstract][Full Text] [Related]
22. O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer.
Santos SN; Junqueira MS; Francisco G; Vilanova M; Magalhães A; Dias Baruffi M; Chammas R; Harris AL; Reis CA; Bernardes ES
Oncotarget; 2016 Dec; 7(50):83570-83587. PubMed ID: 27835877
[TBL] [Abstract][Full Text] [Related]
23. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
[TBL] [Abstract][Full Text] [Related]
24. Chemoenzymatic synthesis of sialylated glycopeptides derived from mucins and T-cell stimulating peptides.
George SK; Schwientek T; Holm B; Reis CA; Clausen H; Kihlberg J
J Am Chem Soc; 2001 Nov; 123(45):11117-25. PubMed ID: 11697954
[TBL] [Abstract][Full Text] [Related]
25. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
26. Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV.
Harduin-Lepers A; Stokes DC; Steelant WF; Samyn-Petit B; Krzewinski-Recchi MA; Vallejo-Ruiz V; Zanetta JP; Augé C; Delannoy P
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):37-48. PubMed ID: 11062056
[TBL] [Abstract][Full Text] [Related]
27. Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation.
Müller S; Hanisch FG
J Biol Chem; 2002 Jul; 277(29):26103-12. PubMed ID: 12000758
[TBL] [Abstract][Full Text] [Related]
28. ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation.
Lakshmanan I; Chaudhary S; Vengoji R; Seshacharyulu P; Rachagani S; Carmicheal J; Jahan R; Atri P; Chirravuri-Venkata R; Gupta R; Marimuthu S; Perumal N; Rauth S; Kaur S; Mallya K; Smith LM; Lele SM; Ponnusamy MP; Nasser MW; Salgia R; Batra SK; Ganti AK
Mol Oncol; 2021 Jul; 15(7):1866-1881. PubMed ID: 33792183
[TBL] [Abstract][Full Text] [Related]
29. Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids.
Loureiro LR; Sousa DP; Ferreira D; Chai W; Lima L; Pereira C; Lopes CB; Correia VG; Silva LM; Li C; Santos LL; Ferreira JA; Barbas A; Palma AS; Novo C; Videira PA
Sci Rep; 2018 Aug; 8(1):12196. PubMed ID: 30111774
[TBL] [Abstract][Full Text] [Related]
30. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
Burchell J; Poulsom R; Hanby A; Whitehouse C; Cooper L; Clausen H; Miles D; Taylor-Papadimitriou J
Glycobiology; 1999 Dec; 9(12):1307-11. PubMed ID: 10561455
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies.
Van Elssen CH; Clausen H; Germeraad WT; Bennet EP; Menheere PP; Bos GM; Vanderlocht J
J Immunol Methods; 2011 Feb; 365(1-2):87-94. PubMed ID: 21194532
[TBL] [Abstract][Full Text] [Related]
33. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms.
Gawlitzek M; Ryll T; Lofgren J; Sliwkowski MB
Biotechnol Bioeng; 2000 Jun; 68(6):637-46. PubMed ID: 10799988
[TBL] [Abstract][Full Text] [Related]
34. Extended core 1 and core 2 branched O-glycans differentially modulate sialyl Lewis X-type L-selectin ligand activity.
Mitoma J; Petryniak B; Hiraoka N; Yeh JC; Lowe JB; Fukuda M
J Biol Chem; 2003 Mar; 278(11):9953-61. PubMed ID: 12529363
[TBL] [Abstract][Full Text] [Related]
35. Linkage-specific action of endogenous sialic acid O-acetyltransferase in Chinese hamster ovary cells.
Shi WX; Chammas R; Varki A
J Biol Chem; 1996 Jun; 271(25):15130-8. PubMed ID: 8662976
[TBL] [Abstract][Full Text] [Related]
36. Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cells.
Barrow H; Tam B; Duckworth CA; Rhodes JM; Yu LG
PLoS One; 2013; 8(3):e59792. PubMed ID: 23536887
[TBL] [Abstract][Full Text] [Related]
37. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
Martin LT; Marth JD; Varki A; Varki NM
J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
[TBL] [Abstract][Full Text] [Related]
40. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
